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Abstract 
 
  As the number one cause of death, cardiovascular disease represents a threat to 
both the economic and social well being of European countries. As a result of a variety of 
coordinated efforts between the European Union (EU), national governments, non-
profits, private industry, and local communities, cardiovascular disease (CVD) has been 
decreasing in most countries in recent years. Measures such as bans on trans fats in 
Denmark, social mobilization and prevention policy in Finland, and nutrition labeling in 
the United Kingdom have had major impacts on heart disease. For instance, Finland’s 
prevention programs have resulted in a 63% reduction in deaths due to CVD 
(Laatikainen, Critchley, Vartiainen, Salomaa, Ketonen, & Capewell, 2005). However, 
other countries, like Greece and Russia, are faced with rising incidences of heart disease 
due to increased economic stress, change from traditional diets, and poor national 
coordination. In this study, I have examined the policies that have been recommended by 
the European Union, as well as individual national policies, to determine that prevention 
and health promotion are the most effective ways to promote a heart healthy lifestyle.  
Preface 
 Cardiovascular disease is of particular interest to me. I have worked with the 
American Heart Association and spent the last year studying the risk factors and causes, 
the social and economic effects, and efforts we can take to avoid its detrimental impact. I 
first became interested following my father’s death from a heart attack. As a completely 
preventable disease, it seems illogical to me that so many people per year die of CVD; I 
did not want anyone else to go through what I went through, and as a result I have 
decided to dedicate my energy to studying the disease. In addition, studying in Europe 
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presented an ideal opportunity for me to do research on CVD due to the uniqueness of the 
EU’s structure and the variation of policies in the region. I was interested to see what 
roles culture, policy, and economics have on the disease and prevention in the region.  
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Introduction 
 As the leading cause of death in Europe, cardiovascular disease (CVD) kills about 
2 million people every year (European Commission, 2015). Cardiovascular disease 
(CVD) is a disease that occurs due to an excess of plaque that builds up in arteries. This 
build up can lead to heart attacks and strokes due to a restriction of blood flow to the 
heart or brain. Risk factors of CVD include: obesity, diabetes, smoking, unhealthy diet, 
sedentary lifestyle, stress, and excessive alcohol intake. In the past 50 years, there has 
been a major epidemiological shift from communicable diseases to non-communicable, 
chronic diseases, such as CVD, diabetes, cancer, and pulmonary diseases. As a result, 
these diseases, and CVD especially, have become a large focus of the European Union 
and the countries impacted. As a part of the study, I have compared policy measures that 
have been implemented by governments in a Western European country, two Northern 
European countries, a Southern European country, and an Eastern European country (the 
United Kingdom, Denmark, Finland, Greece, and Russia, respectively) in response to this 
heart disease epidemic. As a result of coordination in the EU through the EU commission 
and a variety of other heart disease centric organizations, private corporations, non-
profits, local communities, and national governments, Europe has made progress on 
lowering the incidence of heart disease. Comparatively, some countries have done better 
than others. However, Europe and its citizens still face monumental cardiac health issues. 
As has been shown through my research, policy measures that lead to prevention, rather 
than reactive, secondary prevention measures are the most successful in controlling the 
epidemic. Europe must move past the current climate of non-governmental influence and 
the dominance of private corporate influence to follow in the lead of countries like 
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Finland; these measures will result in healthy populations with a lack of heart disease for 
years to come.  
i. Literature Review 
I consulted a variety of works of literature for my research. Most of my research was 
comprised of medical and public health journals covering the issue of heart disease in 
Europe and in specific countries. However, I also reviewed country reports and 
organizational reports on the situations within Europe. Some of these were very specific 
and provided information on country specific programs, others provided general 
information on statistics and rates. Of course, the conclusions of the articles varied based 
on which country or program they were referring to. For instance, articles that I consulted 
that were written on Russia came to a different conclusion on the situation there than 
those that I consulted that were written on the United Kingdom. The largest source 
written of information I used was from the European Society of Cardiology’s “Country of 
the Month” program. These articles summarized a variety of country’s CVD statistics, 
health programs, and prevention policies; these were very helpful in my case studies and 
for comparative understanding.  
ii. Research Questions 
In approaching my interviews, the main questions that I asked depended on the 
organization that I was consulting with. However, the following represent the main 
questions I attempted to answer with my research: 
1) What are the prevention programs that are used in EU countries? 
2) How are these programs helping to prevent CVD? 
3) What are the best approaches for preventing cardiovascular disease? 
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When discussing these issues with European wide organizations such as the European 
Heart Network and European Society of Cardiology I asked more general questions 
regarding the policies of the European Union, the impacts of these policies, and how they 
are accepted or applied in individual countries. When interviewing organizations within 
countries, like the Danish Heart Foundation, I inquired about the specific in-country 
policies, prevention methods, and the impacts of these. Also, importantly, I investigated 
how these countries and organizations applied these policies to the general public. 
Understanding how these countries implement their programs and policies for use with 
the general public is important to know how they can be applied elsewhere in other 
countries where prevention may be lacking or needs improvement. 
iii. Research Methodology 
I gathered my information from a variety of sources and figures. My primary 
information has been gathered and recorded through interviews with professionals. The 
methods of by which I questioned these individuals can be found in the Introduction 
(section ii). I contacted these organizations based on suggestions from Dr. Mattila and my 
own academic research. The European Heart Network (EHN) and the European 
Cardiology Society (ECS) are the largest organizations in the EU dedicated to CVD 
research, funding, and providing recommendations to the EU on what policies to adopt 
and push to member states. In addition, I received a variety of contact recommendations 
from Susanne Løgstrup at the EHN. I contacted these organizations and individuals via 
email and phone and often times had a variety of follow-ups. In addition, I experienced 
non-response from other European organizations, heart foundations, and cardiologists. I 
felt that interviews were my most valuable sources of information due to the 
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organizations’ distinct understanding of the topic, familiarity with the present day 
situation, and their future expectations and visions. As a result, I dedicated the majority 
of my time and qualitative research to interviews. However, I did use a variety of 
secondary sources, like articles from academic journals and organizational/country 
reports. This information was helpful to gain a grasp on background information, specific 
numbers/percentages, and case studies.  
 All my interviewees were aware of the direction of my research and my goals for 
the study. In addition, they all gave verbal permission to me to record the interview. They 
are also entitled to have access to my project as well. I have no conflicts of interests to 
declare. 
Analysis of Cardiovascular Disease Prevention Efforts 
Overview of Europe 
i. Cardiovascular Disease and Risk Factors in Europe 
As Europe is made up of a variety of societies, the main risk factors affecting CVD 
differ in each country; each society has their own factors that play into the manifestation 
of a heart disease epidemic. Variations can be explained by differences in lifestyles, 
governments, and stages of prevention and policy actions. Most notably, each country 
within Europe is in a different stage of the non-communicable disease transition; for 
instance, Finland had the highest rate of Coronary Heart Disease in the world in 1972 and 
it has since decreased, but now Russia holds the position as having the highest rate in the 
world (Mirzaei, Truswell, Taylor, & Leeder, 2008). Despite this, there have been some 
general trends in the continent and some major focuses.  
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As mentioned, CVD kills nearly 2 million people every year in Europe and is 
responsible for 47% of all deaths (European Heart Network and European Society of 
Cardiology, 2012). In Europe, CVD kills slightly more men than women (52% men 
versus 42% women). This is due to the lack of awareness about the disease among 
women and the lack of understanding of the variety of symptoms in women that differ 
from symptoms in men (European Heart Network and European Society of Cardiology, 
2012). CVD is the leading cause of death in both Europe and around the world. Despite 
this, there is often a lack of research and monetary focus placed on the disease; as 
discussed by all of those that I interviewed, there is a much larger focus on cancer within 
the EU Commission, individual governments, and populations. 
The map below shows the mortality rates in Europe by country in men from 0-64 years. 
 
(European Heart Network and European Society of Cardiology, 2012) 
It is important to recognize that the cost of this disease, in both direct and indirect costs, 
are estimated at 196 billion euros per year, whereas the budget of the EU is only 140 
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billion euros per year (Løgstrup); this cost is divided between health care costs (54%), 
productivity loss (24%), and informal care (22%).  
In terms of risk factors, smoking remains the major risk factor of concern for all 
of Europe. Smoking accounts for approximately 20% of all cases of CVD (European 
Heart Network and European Society of Cardiology, 2012). Smoking rates remain high 
throughout Europe, and though there has been a decline in all countries, excluding 
Russia, it has not been as rapid as expected or needed. In fact, among some 
demographics, the decreasing trend is even slower. For example, there has been less of a 
decrease in the prevalence of smoking among women due to the increased social 
acceptability of women smoking. The gender gap is now 32% of men smokers versus 
25% of women smokers. In addition, there is larger prevalence of smoking among the 
lower socioeconomic classes; 52% of unemployed persons are smokers. This percentage 
indicates a problem for countries where economic recessions have occurred, like Greece 
and Russia. Most notably, some countries like Russia have seen a marked rise in the 
smoking prevalence among adolescents. Outside of these countries, smoking among 
adolescents has decreased, but at a slower rate than other demographics (European Heart 
Network and European Society of Cardiology, 2012). Clearly, smoking, in addition to 
other more individualized risk factors like obesity, lack of exercise, etc., represents a 
large threat to Europe.  
ii. Problems with European Policy Implementation 
In introducing policy measures to target CVD and its risk factors, the EU, the EHN, 
and ESC face a variety of problems. Firstly, cardiovascular disease is still not seen as the 
largest threat in Europe, despite its prevalence and social and economic costs. As 
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discussed by Susanne Løgstrup and the other experts I interviewed, cancer is given the 
highest degree of attention by the population and of importance in research and funding 
by the governments. Currently, the research investment in cancer is more than three times 
the investment made into heart disease research (Løgstrup). With a lack of pressure from 
the general population, it is more difficult to get legislation passed or to draw the 
attention of European Parliament. The EHN and ESC work to encourage their members 
to contact their EU representatives and push for policy change; they also work to 
intervene, pre-empt policies, and spread awareness on the problem within Parliament 
through events such as World Heart Day and through co-signing letters to Parliament.  
However, despite increased awareness, there are still barriers that have developed in 
recent years. There has been an increase in the amount of corporate influence throughout 
Europe that has limited the amount of policy change that can occur, and what types of 
policies are implemented. For instance, cancer research is encouraged by large 
pharmaceutical corporations due to the value of investment and the amount of money 
these drugs can produce. Also, developed in 2006, the Nutrition and Health Claims 
Profile is an example of a policy that failed at the EU level due to industry influence. The 
commission was in the process of developing nutrition profiles for certain foods with 
high level of saturated fats, sodium, etc. so warning labels could be placed on packaging; 
however, this effort failed due to its tie with industries and the potential that food 
companies could be economically harmed by this warning labeling. In addition, there is a 
large amount of fragmentation in the EU. The commission has the responsibility to 
develop policies, but has no way to truly enforce this legislation in all member states. As 
a result, only a small number of member states may adopt a specific policy; this is true in 
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the case of the Tobacco Product Directive in which only three countries (the UK, Ireland, 
and France) have adopted it. Finally, there has been a decrease on the EU policy level in 
providing policy recommendation for national governments. There is a new political 
climate of non-intervention; this makes it difficult to create a common standard in all 
European countries (Løgstrup).  
iii. European Programs and Policies 
In response to the threat of CVD and despite the limitations, the EU and European-
wide organizations such as the EHN and ESC have created a variety of programs and 
policy recommendations for their member states. To begin with, the ESC developed 
EUROSPIRE, an observational survey to track the number of people in the EU with CVD 
and to track risk factors, as well how patients respond to treatment (Montaye, De 
Bacquer, De Backer, & Amouyel, 2000). This survey is important to understanding how 
and where to implement prevention plans, as well as their effectiveness. In addition, a 
major step in ensuring that the appropriate policies are delivered to the European 
population was the establishment of the European Heart Health Charter in 2007. As 
discussed by Løgstrup and Reiner, the charter is composed of 23 articles on a variety of 
topics like research, assessment, and programs that are meant to tackle cardiovascular 
disease (Reiner, 2009). At this point, 29 countries have signed onto this agreement. To 
promote this, the EU sponsored the EHN’s program EuroHeart. EuroHeart’s goal is to 
support the efforts of the charter through its primary goals of “mobilizing broad support 
for cardiovascular health promotion and cardiovascular disease prevention with a view to 
achieving stronger cross sector cooperation…, map and analyze national plans, policies, 
and measures…, investigate issues concerning CVD in women…, improve prevention 
	   12	  
practices at primary care level…, and implement and adapt European guidelines on CVD 
prevention to national situations” (EHN, 2007). EuroHeart has since been expanded to 
EuroHeart II to include more work packages on diet and nutrition in Europe. These 
programs culminate with policy recommendations and include workshops and meetings 
at the regional and national levels to help with implementation. However, despite the 
high number of countries who are engaged, there have been issues with national 
implementation due to a lack of national leaders and experts on the issues, a lack of 
funding, and a lack of guidance (Reiner, 2009).  
Similarly, Economics of Chronic Diseases (EConDA) represents another EU funded 
organization established by the EHN, ESC, and other chronic disease focused 
organizations in order to investigate fiscally responsible policies for the prevention of 
CVD, cancer, liver disease, pulmonary disease, and other NCDs. These have resulted in 
specific policy recommendation papers in the last four years on trans fat, alcohol, salt, 
and clean air (Løgstrup).  
In addition to programs that have been established by outside organizations and 
funded by the EU, the Union has also developed other policies targeting risk factors like 
the Tobacco Product Directive mentioned earlier. Mostly, the EU stands to establish 
policy suggestions that are entirely voluntary to member states. For instance, the EU has 
adopted several regulations on food labeling in order to make nutritional information 
more available to consumers. They have also created commissions to encourage physical 
activity in countries and provide recommendations. These policies and platforms require 
and rely on members to commit to devote resources and spread awareness, but, yet again, 
these are voluntary (European Commission, 2015).  
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The figure below shows the format of development, strategy, and accomplishments by the EU 
Platform of Diet, Physical Activity, and Health. 
 
(European Commission, 2015) 
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iv. Analysis of European Polices and the Results of these Policies 
As mentioned previously, the rates of heart disease have been decreasing in most 
countries within Europe in the past years. Much of this can be tied to the work done by 
the EHN, ESC, and EU. For instance, since the introduction of EuroHeart in 2007, 
disease rates have continued to decrease.  
The graph above shows the Coronary Heart Disease (CHD) disease rates by country and by year. 
(European Heart Network and European Society of Cardiology, 2012) 
However, due to the fragmentation, the voluntary nature of EU regulations, and the 
current culture of non-involvement, the EU has not made enough strides in terms of 
prevention. In fact, based on the Reassuring European Attitudes about Cardiovascular 
Treatment Survey (REACT), a large portion of European physicians do not follow the 
guidance the EU provides for them; 19% responded to the survey saying they do not 
follow prevention care guidelines and post-cardiac event treatment. Despite this, 87% of 
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physicians say they believe in prevention efforts (Hobbs & Erhardt, 2002). The EU has 
not made the regulations and measures strict and have not given member countries the 
appropriate tools and resources to enforce the guidelines that health experts within the 
EU recommend. Many of these limitations for physicians include a lack of training on the 
guidelines, and a lack of financial capital; this also applies for countries that want to 
apply EU platforms on a national level. This lack of enhanced enforcement on behalf of 
the EU has not only lead to cardiovascular disease in individuals, but also led patients 
astray following a cardiac event. Based on the same REACT survey, six months after a 
cardiac event, 19% of individuals were still smoking, 25% were still overweight, 53% 
continued to be hypertensive, and 86% still had high cholesterol (Hobbs & Erhardt, 
2002). Overall, in coordination with the EHN and ESC the EU has made progress in 
combatting CVD with prevention and with the introduction of the European Heart Health 
Charter and EuroHeart; however, these programs need better methods of enforcement and 
better support at the national level in order to be truly successful.  
Country Specific Problems and Policies 
i. United Kingdom 
The United Kingdom has conducted a dynamic response to the issues presented by 
CVD. Currently, cardiovascular disease causes 160,000 deaths per year, or roughly a 
quarter of all deaths. Furthermore, CHD is the biggest killer in the UK, accounting for 
73,000 deaths. However, the deaths due to CHD have been halved since 1981 (Unal, 
Critchley, & Capewell, 2005). Currently, each patient that suffers from CVD costs the 
UK about 7000 euros per year (this is about 4900 pounds per year) (Kruse, Davidsen, 
Gyrd-Hansen, Madsen, & Sorensen, 2008). In total, the cost of treating these patients and 
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dealing with lost productivity due to disability and death accounts for 19 billion pounds 
per year (British Heart Foundation, 2015). As a response to the number of deaths and the 
high cost, the UK has introduced a variety of prevention programs for high-risk 
individuals and the general population alike. Unfortunately, according to Simon Gillespie 
at the British Heart Foundation, CVD is not recognized as a priority among UK citizens; 
again, like other European nations, citizens see cancer as the biggest threat because they 
see CVD as a condition that is controllable and someone’s “fault.” Currently, of those 
who donate to charities, 40% donate to the British Cancer Foundation versus only 20% to 
the BHF. To handle this, the BHF is currently working to change public perception on the 
development of CVD. Also, like many other governments, the British government has 
begun to lower funding for prevention tactics that will contribute to a healthier 
population. Despite this, the BHF are working to target risk factors that contribute to 
heart disease. 
Currently, health inequalities contribute strongly to the variety of risk factors that 
impact the rates of CVD in the UK. As cited by Gillespie, there are large differences in 
health in the varying areas of the UK based on the average SES. In areas with lower 
incomes, the population is more sedentary, less healthy in terms of nutrition, and heavier 
smokers. For instance, Gillespie relayed information about the town of Blackpool, a 
small community that was previously a popular spot for vacationers. After the tourism 
industry dissipated, the health and incomes in the community worsened. Now, smoking is 
at an all-time high and there is a high rate of smoking during pregnancy. Of course, 
outside of these communities, risk factors are still prevalent. In 2015 in the UK, 3.3 
million adults have diabetes, smoking rates vary between 18-22% based on the 
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geographical area, about a third of the population, both children and adults alike, are 
obese, and 50% of women and 33% of men do not get enough exercise (British Heart 
Foundation, 2015). Additional percentages of the population do not eat enough fruits and 
vegetables and have high blood pressure and cholesterol.  
The table below depicts the percentages of risk factors that are prevalent in the UK/England. 
(Furze & Mills, 2015) 
  
To combat these programs, the BHF has pushed for research, policy, funding, and 
education on prevention and lifestyle changes. According to Gillespie, the main focus of 
the BHF is research on the best ways to impact rates of CVD and new treatment methods. 
However, there is a large amount of work that goes into primary prevention as well. For 
instance, the UK adopted the policy recommendation from the EU on front of pack 
nutrition labeling. As mentioned in the “Overview of Europe” Section iii, as of 2015 this 
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labeling system involves a color-coded scheme to indicate to the consumers if the 
food/beverage involves healthy levels of fat, sugar, etc. (UK Department of Health, 
2013). In addition, there have been steps taken to lower the prevalence of and impact of 
smoking upon the English population. Tobacco control is of particular concern in the UK 
because of the inability to respond to the effects of smoking on a secondary basis; the 
best way to prevent risk from smoking is to stop individuals from smoking to begin with 
(Unal, Critchley, & Capewell, 2005). According to Gillespie, most recently in October of 
2015, it was made illegal to smoke in a car with children present; the law helps to protect 
children who are unable to make a choice about their exposure to secondary smoke. In 
addition, in 2009 a law was passed to ban the sale of tobacco products/cigarettes in 
vending machines. As a result of these policies and others, smoking in the UK has 
dropped by 33% (Unal, Critchley, & Capewell, 2005).  
In addition, there have been a variety of messaging programs targeted for members of 
the population. Health at Work exists as a program that distributes information to 
employees about healthy lifestyle choices, Heart Healthy Kits and Pass It On is training 
for health professionals, there is prevention messaging for ethnic minorities, and the “10 
Minutes to Change Your Life” educational series is about small changes that can be made 
in daily lifestyle. In addition, the Hearty Lives Programme by the BHF tests different 
programs on their implementation and service; these programs have been designed to 
impact nearly every group of the population, from urban to rural residents, wealthy to 
lower income residents, young and old, and ethnic minorities. In addition, on a broader 
scale, the National Health System (NHS) provides five yearly free health checks to 40-74 
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year olds that have not previously been diagnosed with CVD; this is a way of 
encouraging early detection (Furze & Mills, 2015). 
In addition to these, the BHF has been the head of a few other larger, more 
geographically targeted programs. These programs have been primarily based in the 
Merseyside county of England with the help of the Heart of Mersey organization. In 
Mersey in 2005, the population there suffered from 30% more heart disease than any 
other part of the country. As a response, a program was undertaken to develop a smoke 
free environment and to lower the consumption of unhealthy food and beverages. This 
program is very similar to the one undertaken in North Karelia in Finland that will be 
discussed later (Lloyd-Williams, Capewell, Ireland, & Birt, 2008). More recently, in a 
study discussed by Gillespie and still not completely published, the Heart Lives 
Childhood Obesity Programme, based in the same area, is a targeted program that has 
been developed to impact the lifestyle habits of “Looked After Children” (LAC). LAC 
are foster care children; they are a part of a high risk group due to the lack of stable 
parenting and education. The program was designed to provide physical activity and 
healthy cooking workshops and education. Though I cannot provide specific numbers 
because the study remains unpublished as of now, the program enabled the majority of 
LAC to feel empowered to make healthy decisions, and the program improved their lives 
on both a health and a social level.  
The United Kingdom’s focus on prevention programs on a variety of levels has made 
a large impact on the health of citizens.  Though secondary prevention, through 
medications like beta-blockers, has increased due to governmental policy changes, 
primary prevention remains a strong way to target heart disease (DeWilde, Carey, 
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Richards, Whincup, & Cook, 2008). In fact, through the UK’s large programs it has been 
shown that primary prevention has an advantage over secondary prevention. In the UK, 
58% of the fall in CVD mortality has been linked to a lowering of the risk factors. 
Furthermore, primary prevention has a seven times greater advantage over secondary 
prevention. In terms of gaining life years, in a study done with patients, a patient treated 
with primary prevention methods gained an average of 21 years of life, but one treated 
only with secondary prevention gained seven and a half years of life (Unal, Critchley, & 
Capewell, 2005). Clearly, primary prevention has had a great impact on the UK and can 
have a great impact elsewhere. Though rates of smoking, obesity, and CVD remain high 
in the UK, proactive primary prevention has taken great strides in lowering the risk for 
many citizens.  
The graph below demonstrates the number of deaths prevented with methods of primary 
prevention versus secondary prevention in the UK. 
 (Unal, Critchley, & Capewell, 2005) 
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ii. Denmark 
Denmark has done extraordinarily well in terms of heart disease prevention. Since 
1985, Denmark has experienced a 70% reduction in the amount of deaths due to CVD 
(EurActive.com, 2014). This was due to a variety of programs that have been introduced 
on a national and local level. However, in policy climate, Denmark is reflective of the 
European Union in many ways. I discussed this situation in an interview with Simon 
Rask at the Danish Heart Foundation. Similar to the EU and UK, cancer in Denmark is 
seen to be the biggest health threat; though the government and population recognize 
CVD as a problem, the Danish Cancer Society generates more attention and money than 
the Danish Heart Foundation. In addition, the Danish government, in coordination with 
the Danish Cancer Society and Danish Heart Foundation has put the most emphasis on 
smoking prevention. They have targeted this factor due to the negative effect it has on a 
variety of diseases, CVD only being one of them. As discussed by Rask, the major 
change in smoking habits came eight years ago in coordination with a government policy 
that prohibited smoking indoors in public places; this has not only helped decrease 
smoking in the Danish population, but also assisted in lowering the effects of secondhand 
smoke.  
However, the biggest contributor to the decrease in heart disease deaths is Denmark’s 
ban on trans fat. In 2003, Denmark became the first country in the world to ban trans fat 
from food (EurActive.com, 2014).  Trans fat is a high contributor to heart disease and one 
study shows that consuming five grams of trans fat per day is associated with a 25% rise 
in the risk of developing CVD in your lifetime (Restrepo & Rieger, 2015). This ban has 
had a high contribution to the lowered prevalence of CVD, as well as the lowered 
	   22	  
mortality rates. However, to demonstrate the current climate of corporate influence 
within the EU, the Danish government faced a lawsuit from the EU in 2004 due to the 
ban’s interference on free trade; it was seen as discriminatory against companies that sold 
foods with trans fat (EurActive.com, 2014). Though this lawsuit was abandoned in 2007, 
it represents the overwhelming influence that corporations have on health policy today in 
Europe and in the national sphere.  
In addition to the main policies of banning trans fat and smoking in indoor public 
spaces, Denmark has also integrated a variety of other prevention programs into their 
daily life. Both the Danish Heart Foundation and the Danish government have made 
efforts to integrate physical activity into the Danes’ lifestyles. For instance, according to 
Rask, the government has extended the school day for the 80-90% of children in public 
schools to “whole day school.” With this change, the government now requires that 
children exercise for 45 minutes per day at school; though this program is still being 
implemented, the effects it will have on childhood obesity and rates of CVD later on will 
be strong. At the local levels of the Danish Heart Foundation, the communities have 
created “heart paths,” which are marked walking paths in order to encourage aerobic 
exercise among the population. In addition, the infrastructure in place in Denmark favors 
bikers and walkers. As Rask mentioned, in Copenhagen, the capital of Denmark, 45% of 
the population bikes to work.  
Despite all these measures, primary prevention, like in the EU overall, has been 
downgraded. Rask discussed that in recent years, due to the aging population and the 
amount of money it now requires to care for them, money in the country’s budget has 
been moved from primary prevention to other programs supporting the older population 
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and secondary care for them. This shift acknowledges the larger the move to government 
non-intervention that is seen across Europe.  
Other factors that influence heart disease in Denmark include health inequalities that 
limit the population from having the means to understand and access information on heart 
disease prevention. However, as Rask notes, economic situations do not stop consumers 
from having the means to purchase healthy products; food deserts are not a strong 
concern in Denmark. Similarly, the 2008 recession did not have a strong influence on 
heart disease prevention efforts; the aging population has had more effects on the health 
prevention budget than the recession. In addition, diet, excluding trans fat, has only had a 
small influence on the population’s health. Though, as Rask noted, a smaller amount of 
the Danish population eat whole wheat bread now and there is a now higher consumption 
of salt than in the past; the Danish Heart Foundation is in the process of expanding 
programs that target these issues. Overall, Denmark represents a very advanced country 
within the EU. Their policies on trans fat, exercise, and infrastructure promote a healthy 
lifestyle that has overwhelmingly lowered the number of CVD deaths in the country. 
However, like the rest of the EU, there have been pullbacks in terms of primary 
prevention due to budget changes and corporate influence; this will have a negative effect 
on generations to come. However, Denmark has succeeded in making the healthy choice 
the easy choice in many cases.  
iii. Finland 
Finland has one of the most innovative and unique situations related to cardiovascular 
disease. CVD mortality rates have dropped 65% since the 1970s (World Health 
Organization, 2015). Actual CVD incidence has dropped by 80% since the 1970s 
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(Pulska, 2009). In the late 1960s and 1970s, Finland had the highest rate of heart disease 
deaths in the world with about 85% dying from the disease. In addition, one particular 
area of Finland, North Karelia, experienced these risk factors more than other areas, and 
as a result, had a higher rate of CVD than the average in Finland. Before this, a 
combination of risk factors and high-risk behavior contributed to the disease in Finland 
and created an environment which death by heart disease was expected. However, an 
intense prevention program and lifestyle switch implemented by Pekka Puska, a Finnish 
doctor and expert changed the population dramatically. As a result, the average Finnish 
person has gained 10 years on their life expectancy (Pulska, 2009). 
 
The graph above depicts the peak of the heart disease epidemic in Finland and its gradual 
decline. 
 (World Health Organization, 2015) 
 
In Finland in 1965, butter use by the average Finnish person was at 18kg per day and 
fat composed 40% of the diet. In addition, the Finnish population consumed very few 
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fruits and vegetables and was extremely sedentary. Cholesterol was extremely high in the 
population. Some reasons for the poor diet included a payment program in which dairy 
farmers were paid based on the percentage of milk fat within their milk instead of the 
protein. This led to a society that consumed milk largely laden with unhealthy fats. In 
addition, the diet involved a large proportion of butter for cooking and consumption, and 
there were fat fillers in many traditional dishes, like sausage. For fruits and vegetables, 
consumption was limited due to a lack of production and short growing seasons; the 
Finnish population did not import a large amount of fruits and vegetables due to their 
high prices. There was also a high rate of smoking. Like the rest of Europe, much of the 
Finnish population adopted smoking as a part of daily life following its major 
introduction to society during and post- World War II (Buettner, 2015).  However, the 
largest single indicator and risk factor for heart disease in Finland was high cholesterol; 
this was the target of many of the prevention programs (Laatikainen, Critchley, 
Vartiainen, Salomaa, Ketonen, & Capewell, 2005). 
 
The above graphs depict the butter and fat consumptions in Finland. 
 (Pulska, 2009) 
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To handle the high incidence of heart disease in Finland and in North Karelia in 
particular, Puska introduced small programs in North Karelia and then applied them to 
Finland on a broader scale. A large degree of social mobilization occurred; for instance, 
an outreach organization called the Martha Organization reached out to local churches, 
schools, and families and taught them how to cook meals with vegetables so vegetables 
could be incorporated into the Finnish diet on a daily basis (Buettner, 2015). In addition, 
Puska and his team recruited ambassadors in the community, who were often times 
community stakeholders, to relay the importance of diet and exercise. On a broader level, 
there was national coordination with schools for nutrition and physical activity education, 
and coordination with the private sector, NGOs, and international organizations. The 
WHO (World Health Organization) specifically assisted and guided Finland as the 
Finnish government adopted the WHO Global Strategy on Diet, Physical Activity, and 
Health (Petrukhin & Lunina, 2011). On a governmental and private level, the government 
restructured the way that farmers were paid, causing them to reduce the amount of milk 
fat in their dairy products. In addition, in a large step tobacco advertising and smoking in 
public spaces was banned (World Health Organization, 2015). In addition, Puska and the 
government worked with private corporations to change the composition of the foods 
they produced. For instance, Puska lobbied sausage producers to remove a fatty, salty 
filler from their food and replace it with another filler composed of mushrooms. Though 
there was some hesitance from the companies at first out of fear of losing money, the 
change resulted in greater sales and healthier consumption. In addition, Puska worked 
with companies to establish a process of freezing local fruits and vegetables (particularly 
berries) during harvest season so they could be distributed and consumed year round. 
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Finally, through work with private corporations, NGOs, and the communities, changes 
were made in restaurants and stores as a result of bans and lifestyle changes; these 
included the introduction of salad bars in restaurants, butter replacements in stores and 
restaurants, and a ban on free soda refills at restaurants.  
As we know as a result of these programs, the Finnish and those in North Karelia 
have gained a significant number of years on their life expectancy, and the rate of heart 
disease in the population has decreased by 80%. From the study in North Karelia, we 
learned about the great impacts that lowering risk factors and introducing prevention 
programs can have on the population. For instance, studies in Finland showed that by 
lowering cholesterol by one point can lower the risk of developing heart disease by two 
points (Buettner, 2015). In addition, this study and program has shown that prevention 
programs are much more affordable and cost effective than the high-risk approach. 
Though both were used, the prevention approached demonstrated a clear advantage in the 
amount of lives affected and saved. It is most effective to target the largest risk factors 
and work on those factors in order to impact the entire population (Pulska, 2009). These 
changes can occur in the population without the members completely realizing they are 
occurring. For instance, a Finnish victim of heart disease recognized that he could not 
pinpoint the exact time that his diet and lifestyle changed for the better; he said that it 
“just happened” (Buettner, 2015). Clearly, the population approach to prevention can 
have a large impact. Though there are some barriers to implementation, these can be 
overcome with international support, coordination between sectors, work with the 
community, flexible intervention based on the individual community, and industry 
collaboration and understanding (Pulska, 2009). This program has been shown to be so 
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effective that it has become the model in other programs in the United Kingdom 
(Merseyside) and in the United States in the Blue Zone Project (Buettner, 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The two graphs shown here 
depict the impact of the project 
in Finland on CVD risk factors 
and mortality rates.  
(Pulska, 2009) 
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iv. Switzerland 
Currently, CVD is the main cause of death in Switzerland at 33%; however, mortality 
has deceased by 41% in 20 years (Swiss Info, 2015). This has been a significant drop in 
mortality. There are a variety of factors and programs that play into this change, but this 
mortality drop does not necessarily represent the same drop in prevalence. Currently like 
some other countries in this study, Switzerland does not report on the prevalence of the 
disease, only the mortality. This represents a flaw seen in many European countries 
today. By reporting only the mortality, the country can be missing a large demographic 
facing the disease. For instance, a younger population may be developing the disease, but 
not dying from it yet; also, as people live longer with new medical technology and drugs, 
they will be living longer with CVD. Therefore, mortality is not entirely an accurate 
representation of the situation (Heart Disease in Europe, 2013). 
Switzerland is similar to Denmark in terms of its prevention programs. Like the 
Danish Heart Foundation and BHF, the Swiss Heart Foundation provides education, tests, 
and support to the Swiss population on risk factors like smoking, high blood pressure, 
and obesity (Fondation Suisse de Cardiologie, 2013). Also like the rest of Europe, 
smoking is a major contributor to the rates of heart disease in Switzerland; in 2010, 19% 
of the population reported smoking daily. The National Smoking Stop Smoking Program 
run by the Swiss Society for Smoking Prevention provides education and support to 
individuals trying to quit, as well as education for health professionals on effects of 
smoking and how to help their patients quit. The Swiss Heart Foundation sponsors this 
program. It has helped lower the percentage of smokers by 5% since 2001 (Swiss Society 
for Smoking Prevention, 2015).  
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In addition, as discussed by Adrian Fischer at the Swiss Society of Nutrition, 
there are a large variety of exercise programs in place to encourage physical activity in a 
variety of sectors of the population. There are programs on different levels of government 
to determine policy and maintain infrastructure to promote a healthy populations 
(walking paths, sports clubs, etc.). It has been shown that a targeted approach like this is 
essential to increasing activity  (Stamm, Structural and Cultural Factors Influencing 
Physical Activity in Switzerland, 2005). Similar to Denmark, programs that have resulted 
include a compulsory sport requirement in schools for children. There are also subsidies 
for sports clubs that offer activities for children; the Swiss program “Youth + Sport” 
(Federal Office of Sports, 2015) is an example. There is currently an increase in activity 
level for ages 5-10 which demonstrates that these programs that encourage activity and 
require it in schools are effective. Recently, and similarly to the European climate, we are 
seeing decreasing spending on prevention, there has been a decline in subsidies and 
compulsory sports for adolescents (Swiss Confederation, 2015).  
Despite the programs for physical activity, there is a lack of programs on nutrition 
in Switzerland. As discussed with a nutritionist in Geneva, Gemma Calzada, though the 
Swiss have a culture of eating healthily and organically, there have still been changes in 
diet. The Swiss now consume more sugar and fats then in the past, contributing to heart 
disease. In addition, health inequities make it difficult for all families to afford the 
organically produced food that is often more healthy than non-organic food; families will 
choose the most convenient option. There are small programs in school for children on 
nutrition, but nothing for adults and nothing substantial. In terms of enforcement of EU 
recommendations, Switzerland abides by voluntary nutrition labeling.  
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In general, Switzerland has done well in prevention by incentivizing physical 
activity and exemplifying a healthy diet as it is in the top five of countries with the lowest 
incidence of heart disease; however, more programs could improve the situation 
extraordinarily. In fact, the lower rates in Switzerland are more tied to historic eating 
habits and fitness culture than programs that are currently in place. In addition, a shift 
away from a focus on mortality would help to provide a more well rounded view and 
understanding of the CVD situation in Switzerland.  
v. Greece 
As a Southern European, Mediterranean country, Greece is unique compared to the 
UK, Denmark, Finland and Switzerland. Currently, CVD accounts for approximately 
48% of all deaths in Greece (Vassilaki, Linardakis, & Philalithis, 2014). Even more 
notable, though CVD mortality rates have been dropping, the rate at which they have 
dropped is significantly lower than the rest of Europe. Within Greece there has only been 
a 10% decline, while the remainder of the EU has experienced a 36% drop (Vassilaki, 
Linardakis, & Philalithis, 2014). In addition, Greece was the only EU country to increase 
in rates from 1980 to 2009 (Vassilaki, Linardakis, & Philalithis, 2014). Since 2009, 
however, the rates have again decreased. There are a variety of factors in Greece that are 
playing into these rates and changes.  
Greece currently faces a great set of risk factors including stress, unhealthy diets, and 
a high rate of smoking. Overwhelmingly so, smoking is one of the greatest risk factors. 
Of those who experienced a cardiac event, 33% reported being active smokers; another 
third reported having quit smoking before the event. In addition to these individuals, 48% 
of non-smokers responded that they were exposed to secondhand smoke at work or at 
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home; though not as strong as being an active smoker, secondhand smoking can clearly 
have a grave impact on health. In addition, adolescents are active smokers; 10-20% of 
boys report smoking and 5-15% of girls report the same (Konstantinos, 2015). In addition 
to smoking, obesity, hypertension, and high cholesterol all have an impact on heart 
disease rates.  
One of the main reasons for the high, increasing rates of obesity in the population is 
the shift away from the traditional Mediterranean diet; this is one of the biggest factors in 
CVD growth in this region, as well as Greece. Traditionally, a Mediterranean diet is 
composed of whole wheat, fruits, vegetables, and olive oil. In particular, olive oil has 
been shown to be protective to the development of CVD. However, with urbanization and 
globalization, the role of olive oil in the population has been diminished and there has 
been a rise in consumption of butter and other fats. This has played an especially 
important role in certain areas of Greece; for example, the Greek island of Crete has the 
highest fast food consumption out of the other 12 Mediterranean islands in the 
surrounding area (Vassilaki, Linardakis, & Philalithis, 2014). In addition to a changing 
diet, low socioeconomic states (SES) and stress has played a role in the development of 
obesity and the other risk factors. In recent years, Greece has suffered a large economic 
downturn that has contributed to a rise in poverty and financial hardship. This not only 
contributes to stress, which is correlated to a rise in heart disease, but also makes it harder 
for individuals to purchase healthy food. Like smoking, the result of these changes has 
been seen noticeably in the younger generations. They have been more accepting and 
open to embracing a Western diet and abandoning their traditional diet.  
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Below is a table depicting the rates of current risk factors in Greece. The rate of smoking has 
diminished since 2001, but obesity, hypertension, etc. are noticeably on the rise. 
 (Konstantinos, 2015) 
 
The prevalence of smoking in the younger generations, and the rise in other risk 
factors in the young population, indicate that a shift needs to be made in public health in 
Greece to an “upstream population approach.” This means that the younger generation 
would be targeted in prevention efforts to create a healthier society in the future. 
However, there are currently a variety of prevention programs that target the general 
population. The main program in place now is CHALLENGE. CHALLENGE is a 
program designed for patients and doctors in order to implement a registry to track 
patients, cardiac episodes, and encourage follow-up appointments; currently over 1,600 
patients are registered (Konstantinos, 2015). This program will help with prognosis 
overall in the future. In addition, there are a variety of other registries designed to track 
patients with hypertension and other risk factors. In addition, there are two main 
campaigns designed to educate the general public. One is for education on 
cardiopulmonary resuscitation (CPR) and the other, “ACT NOW, SAVE A LIFE” is for 
education on the symptoms of heart attack and stroke in order to encourage victims and 
those around them to seek immediate medical help (Konstantinos, 2015). Finally, there is 
a national smoking prevention program that has integrated social media, guides, and 
advertisements on TV/radio. The campaign educates on the effects of smoking, 
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encourages quitting, and provides support to those who are trying to quit (Konstantinos, 
2015). Related to this, there have been bans on smoking in indoor public spaces.  
 Despite these programs, risk factors and CVD remain high. Unfortunately, 
smoking bans have not been enforced properly, and 33% of the population still reports 
smoking (Konstantinos, 2015). In addition, though the programs in place do help patients 
who have experienced a cardiac event, there are no programs, besides the inadequate 
smoking ban, that truly provide primary prevention. Also, there are no policies programs 
to limit the effect that globalization has had on diet and the other risk factors. In addition, 
due to the financial crisis in Greece, many patients cannot afford to stay in the cardiac 
support programs that are currently in place. Finally, the government has pulled money 
away from primary prevention due to the financial crisis (Konstantinos, 2015). This lack 
of prevention funding in a time where the public cannot afford to eat a nutritious diet, 
exercise, or get the medical care they need indicates that Greece’s rates in heart disease 
may begin to slowly rise yet again (Vassilaki, Linardakis, & Philalithis, 2014).  
vi. Russia 
Russia currently holds the position for the highest rate of CVD in the world. As of 
2013, CVD was responsible for 57% of all deaths (Petrukhin & Lunina, 2011). In 2013 
when 20.5 million adults underwent health screening, 44% already had an NCD and 23% 
were at risk for developing CVD (Boytsov, 2014). Though now slowly decreasing, this 
exorbitantly high rate has arisen out of a combination of various risk factors and the 
historical and present political situation. To begin, at the start of the epidemiological 
transition to non-communicable diseases, Russia was still the Soviet Union. During this 
time, much of the country was impoverished, there was a lack of funding for health care, 
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and the government was focusing much of it health action on communicable diseases. As 
a result, Russia missed a crucial opportunity to begin to target chronic diseases and 
implement health policies that would have an effect today (Petrukhin & Lunina, 2011). 
Unfortunately, the lack of health care expenditure on prevention continues today in 
Russia. Health expenditure only accounts for 3% of the Russian GDP; this has been 
further reduced in recent years (Petrukhin & Lunina, 2011). 
In addition, the prevalence of risk factors and the variety of such have a great impact 
on the rates of CVD within Russia. The primary risk factor seen in Russia is unique 
compared to the rest of Europe. In Russia, the largest factors are the drinking rates and 
the alcohol consumption within the nation. Excessive alcohol consumption currently 
accounts for 45.6% of all cardiac deaths (Petrukhin & Lunina, 2011). However, like the 
majority of Europe, smoking is also still a large risk factor in Russia; about 23% of the 
population currently smokes. Though smoking has decreased somewhat in men in the last 
10 years, smoking among women has increased by 50% (Boytsov, 2014). This increase, 
like in other European countries, is tied to the increase in the view that it is socially 
acceptable for women to smoke. In Russia, 29% of all CVD deaths are due to smoking 
(Petrukhin & Lunina, 2011). In addition to these main risk factors, the population is very 
sedentary, with about 33% of the population lacking sufficient physical activity (Boytsov, 
2014), and they also consume a poor, non-nutritious diet. Russians consume a large 
proportion of animal fat (about 32-36% of their diet) (Boytsov, 2014). Poor nutrition 
accounts for 29% of all CVD deaths (Petrukhin & Lunina, 2011). This contributes to high 
blood pressure, which 42% of the population currently has (Petrukhin & Lunina, 2011).  
In addition to these factors health inequality plays a large role in the development of 
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CVD. Many people do not have access to areas to exercise, healthy foods, or proper 
health facilities because of their socioeconomic status (SES). In fact, health improves by 
33% in higher income groups within Russia (Petrukhin & Lunina, 2011).  
To handle the risk factors and the rise of CVD within Russia, the government has 
attempted to introduce a variety of prevention programs and policies. In 2014, the Health 
Ministry created the protocol, “Disease Prevention and Promotion of Healthy Lifestyle: 
Development of Primary Healthcare,” which focuses on improving care and prevention 
for NCDs (Boytsov, 2014). In this directive, the government is attempting to increase the 
number of healthcare professionals available, increase those familiar with prevention, 
increase research, and increase the efficiency of the healthcare prevention system. In 
addition, in 2007 the Russian National Society for Preventative Cardiology was 
established, and in 2011 the first guidelines for preventing CVD were released (Boytsov, 
2014). To follow along with this, the government and Russian Health Ministry have 
established free screening for adults and more recently, screening for children. In 
addition, there are programs monitoring the new prevention and care efforts and there are 
conferences between the Russian Society for Preventive Cardiology and other European 
cardiology organizations (Boytsov, 2014).  
 Despite these efforts, Russia faces severe challenges with implementation due to 
the size of the population and the inaccessibility of some areas of the country (Boytsov, 
2014). In addition, there is still a lack of legislation tied to prevention, a lack of 
leadership on the subject, and most importantly a lack of funding; coordination is very 
difficult in the Russian government due to these factors. Also, like other European 
countries, Russia faces a large private interest and lobby in tobacco. Despite the effects 
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that tobacco has on the health of the population, it has been hard for the Russian 
government to implement bans, restrictions, and the World Health Organization (WHO) 
tobacco framework due to the influence that the tobacco lobby has in Russia. Though the 
framework has been ratified, there have been restrictions and problems implementing it 
(Petrukhin & Lunina, 2011). This makes progress difficult. As a historically 
disadvantaged country, Russia needs to make strides in order to lower their burden of 
heart disease before it takes a greater toll on their society. 
Conclusion 
 After a complex examination of the cardiovascular disease situations in the 
European Union and individual countries, it is evident that primary prevention can have a 
large positive impact. Currently, CVD is the main cause of death in Europe and costs 
countries an overwhelmingly large amount of money and lives. The EU, along with the 
EHN and the ESC, have attempted to lower the burden across Europe through programs 
that assist governments in implementing prevention programs, track progress, and 
provide guidelines; however, the EU faces political, financial, and structural barriers. In 
looking at individual European countries, we see many of the same boundaries. I have 
examined six countries based on their rates, programs, and geographical location. The 
UK, as a Western European country, has made strides in lowering the CVD rates through 
broad prevention policies that target a wide array of the population; they have had 
incredible success despite political barriers and high rates of obesity. Both Finland and 
Denmark as Northern European, Nordic countries have had huge successes as well. In 
Finland, a broad population approach has completely changed the lifestyle and cut deaths 
by over half. Denmark’s policy on banning trans fat has had a similar, yet not as broad 
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result. Switzerland, as a central European country does extraordinarily well in terms of 
heart disease rates, but this is based more on cultural eating and exercise habits; the 
country lacks prevention programs. Greece as a southern, Mediterranean country faces a 
variety of limitations due to the current economic crisis and transition away from 
Mediterranean diet. The lack of properly implemented prevention efforts there explains 
the slow decrease in CVD rates and the potential for a rise in the near future. Finally, 
Russia has a severe historical disadvantage that has resulted in the highest rates of CVD 
in Europe. A lack of leadership, as well as the strong presence of private corporate 
lobbying, explains the lack of control of risk factors and high CVD rates. When looking 
at these countries it is evident that those who have taken primary prevention measures, 
such as trans fat bans, nutritional labeling, and social mobilization, have had the largest 
decreases in CVD. Moreover, primary prevention that lowers risk factors in Europe has 
been responsible for more than 50% of the reductions seen in CVD rates (Montaye, De 
Bacquer, De Backer, & Amouyel, 2000). However, because no country faces the exact 
same risk factors, medical conditions, and societal conditions, it is impossible to 
generalize one primary prevention approach for all European countries. To help control 
the development of CVD and limit its impact, we must take examples from Finland, 
Denmark, and the UK and apply them to countries like Greece and Russia with 
individualized research to see the most change and save the most lives. Regardless of the 
specific policies taken to combat countries risk factors, it is important that these policies 
be progressive, population based, and properly led and funded. Most importantly, 
programs that target risk factors and engage in primary prevention are the most effective 
to saving lives from cardiovascular disease. 
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Abbreviation List 
• Cardiovascular Disease (CVD) 
• Coronary Heart Disease (CHD) 
• Non-Communicable Disease (NCD) 
• European Union (EU) 
• World Health Organization (WHO) 
• Socioeconomic Status (SES) 
• European Heart Network (EHN) 
• European Society of Cardiology (ESC) 
• Economics of Chronic Diseases (EConDA) 
• United Kingdom (UK) 
• National Health Service (NHS) 
• British Heart Foundation (BHF) 
• Danish Heart Foundation (DHF) 
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